Patents by Inventor Masanori Fukushima
Masanori Fukushima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240167117Abstract: A method for producing a hot-rolled steel sheet which enables predicting a temperature history of unevenness of the end face of a coil includes: measuring a surface temperature of hot-rolled strip-shaped steel; calculating a temperature history in a natural cooling state after coiling, assuming that the strip-shaped steel has been coiled without unevenness on an end face, based on the surface temperature measured in the measurement step; actually coiling the strip-shaped steel after the measurement step; scanning with a displacement meter, an end face of a coil formed in the coiling step, and deriving a size of the unevenness of the end face over a radius of the coil; and predicting a temperature history of the unevenness in a natural cooling state using: the temperature history calculated in the first calculation step; and the size of the unevenness derived in the derivation step.Type: ApplicationFiled: June 15, 2021Publication date: May 23, 2024Applicant: Kabushiki Kaisha Kobe Seiko Sho (Kobe Steel, Ltd.)Inventors: Koki FUKUSHIMA, Yuta SANO, Masanori KOBAYASHI, Toma KITAGAWA, Toshio MURAKAMI, Takahiro OHARA, Masahiro INUI, Takeshi IIJIMA, Takashi TERAOKA, Takuma YONEDA, Kohei ODO, Shun HARADA
-
Patent number: 11925633Abstract: Provided is a drug superior for preventing and/or treating dementia. It contains a carbostyril derivative of the following formula (1) (wherein R is a cycloalkyl group, A is a lower alkyl group, and a single bond or a double bond is present between the 3-position and the 4-position of the carbostyril nucleus) and dihydroquercetin.Type: GrantFiled: December 18, 2020Date of Patent: March 12, 2024Assignee: NATIONAL CEREBRAL AND CARDIOVASCULAR CENTERInventors: Tadamasa Matsumoto, Masafumi Ihara, Satoshi Saito, Masanori Fukushima
-
Publication number: 20230235291Abstract: This invention relates to a tissue construct comprising a core portion having a recess and composed of fibrous connective tissue, and loose fibrous somatic stem cell-accumulated tissue comprising type III collagen and somatic stem cells which is formed in the recess; a device for producing the same; and a method for collecting somatic stem cells from the tissue construct.Type: ApplicationFiled: May 28, 2021Publication date: July 27, 2023Applicant: BIOTUBE CO., LTD.Inventors: Yasuhide NAKAYAMA, Yasushi SATO, Ryosuke IWAI, Masanori FUKUSHIMA, Hiroshi TAKENAKA
-
Publication number: 20230190816Abstract: The effect of physical exercise performed on a physical function of a subject with an irreversibly reduced physical function is promoted. Bone marrow mononuclear cells, CD34-positive cells, CD133-positive cells, or stem cells are contained. The central and peripheral nerves communicate intimately with each other. When these cells are administered to a subject, and the subject performs an appropriate physical exercise, the reduced physical function can be dramatically improved. The physical exercise .is, for example, physical exercise that stimulates both of brain and peripheral nerves based on the interactive biofeedback theory. Thus, for example, when bone marrow mononuclear cells are administered to a patient with a sequela of cerebral infarction, and the patient performs an appropriate physical exercise, the effect of functional recovery from the sequela of the cerebral infarction is promoted.Type: ApplicationFiled: November 26, 2020Publication date: June 22, 2023Applicant: Foundation for Biomedical Research and Innovation at KobeInventors: Akihiko TAGUCHI, Yuko OGAWA, Yuka OKINAKA, Masanori FUKUSHIMA, Atsuo YAMANAKA
-
Patent number: 11323057Abstract: The present invention reduces electric power consumption of a network inverter. The inverter (1a, 1b, 1c) includes: an MPU (20a, 20b, 20c); and a power supply (10) configured to carry out electric power delivery to the MPU (20a, 20b, 20c) and to a power source circuit (40). In a case where the inverter (1a, 1b, 1c) is to enter a standby state, an electric power delivery control circuit (22) of the MPU (20a, 20b, 20c) blocks electric power delivery to the power source circuit (40).Type: GrantFiled: October 29, 2018Date of Patent: May 3, 2022Assignee: OMRON CORPORATIONInventors: Masanori Fukushima, Ryoichi Watanabe, Hiroyuki Tateyama
-
Publication number: 20220011297Abstract: A method may predict risk of onset of severe interstitial pneumonia caused by an immune checkpoint inhibitor to achieve a safe and highly effective cancer immunotherapy. Any one or more selected from: (a) cell count or proportion of V?2+?? T cells in peripheral blood mononuclear cells isolated from a subject; (b) cell count or proportion of V?2+?? T cells after antigenic stimulation in peripheral blood mononuclear cells isolated from a subject; (c) cell count or proportion of V?2+?? T cells in peripheral blood T cells isolated from a subject; and (d) cell count or proportion of V?2+?? T cells after antigenic stimulation in peripheral blood T cells isolated from a subject are measured, and the risk of onset of severe interstitial pneumonia is predicted by using the cell count or proportion as an index.Type: ApplicationFiled: October 1, 2019Publication date: January 13, 2022Applicants: NAGASAKI UNIVERSITY, Foundation for Biomedical Research and Innovation at KobeInventors: Yoshimasa TANAKA, Hiroaki SENJU, Hiroshi MUKAE, Masanori FUKUSHIMA
-
Patent number: 11166995Abstract: The present invention provides an anticancer agent containing the following (1) and (2): (1) HVJ-E (hemagglutinating virus of Japan envelope), (2) an inhibitor of an immune checkpoint protein.Type: GrantFiled: November 1, 2017Date of Patent: November 9, 2021Assignees: OSAKA UNIVERSITY, GENOMIDEA INC.Inventors: Yasufumi Kaneda, Kazuma Sakura, Tomoyuki Nishikawa, Masanori Fukushima, Toshihiro Nakajima
-
Patent number: 11114973Abstract: In a technique for reducing the number of input terminals of a motor control device, flexibility of designing is improved. A terminal allocating section (23) is provided for setting, in accordance with selection by a user, which of a plurality of input terminals (11) is to be allocated to each of a plurality of function input terminals (21).Type: GrantFiled: October 25, 2018Date of Patent: September 7, 2021Assignee: OMRON CorporationInventors: Masanori Fukushima, Ryoichi Watanabe, Kimikazu Kubo
-
Publication number: 20210100790Abstract: Provided is a drug superior for preventing and/or treating dementia. It contains a carbostyril derivative of the following formula (1) (wherein R is a cycloalkyl group, A is a lower alkyl group, and a single bond or a double bond is present between the 3-position and the 4-position of the carbostyril nucleus) and dihydroquercetin.Type: ApplicationFiled: December 18, 2020Publication date: April 8, 2021Applicants: NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER, FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBEInventors: Tadamasa MATSUMOTO, Masafumi IHARA, Satoshi SAITO, Masanori FUKUSHIMA
-
Publication number: 20200287500Abstract: In a technique for reducing the number of input terminals of a motor control device, flexibility of designing is improved. A terminal allocating section (23) is provided for setting, in accordance with selection by a user, which of a plurality of input terminals (11) is to be allocated to each of a plurality of function input terminals (21).Type: ApplicationFiled: October 25, 2018Publication date: September 10, 2020Applicant: OMRON CorporationInventors: Masanori FUKUSHIMA, Ryoichi WATANABE, Kimikazu KUBO
-
Publication number: 20200252019Abstract: The present invention reduces electric power consumption of a network inverter. The inverter (1a, 1b, 1c) includes: an MPU (20a, 20b, 20c); and a power supply (10) configured to carry out electric power delivery to the MPU (20a, 20b, 20c) and to a power source circuit (40). In a case where the inverter (1a, 1b, 1c) is to enter a standby state, an electric power delivery control circuit (22) of the MPU (20a, 20b, 20c) blocks electric power delivery to the power source circuit (40).Type: ApplicationFiled: October 29, 2018Publication date: August 6, 2020Applicant: OMRON CorporationInventors: Masanori FUKUSHIMA, Ryoichi WATANABE, Hiroyuki TATEYAMA
-
Publication number: 20190358276Abstract: The present invention relates to a medicament for preventing and/or treating cognitive impairment and/or a neurodegenerative disease with accumulation of a prionoid, comprising a Sendai virus envelope as an active ingredient and combined application of the medicament and an immune checkpoint inhibitor.Type: ApplicationFiled: December 6, 2017Publication date: November 28, 2019Applicants: OSAKA UNIVERSITY, FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE, GENOMIDEA INC.Inventors: Yasufumi KANEDA, Masanori FUKUSHIMA, Toshihiro NAKAJIMA
-
Publication number: 20190275091Abstract: The present invention provides an anticancer agent containing the following (1) and (2): (1) HVJ-E (hemagglutinating virus of Japan envelope), (2) an inhibitor of an immune checkpoint protein.Type: ApplicationFiled: November 1, 2017Publication date: September 12, 2019Applicants: OSAKA UNIVERSITY, GENOMIDEA INC.Inventors: Yasufumi KANEDA, Kazuma SAKURA, Tomoyuki NISHIKAWA, Masanori FUKUSHIMA, Toshihiro NAKAJIMA
-
Publication number: 20190142820Abstract: Provided is a drug superior for preventing and/or treating dementia. It contains a carbostyril derivative of the following formula (1) (wherein R is a cycloalkyl group, A is a lower alkyl group, and a single bond or a double bond is present between the 3-position and the 4-position of the carbostyril nucleus) and dihydroquercetin.Type: ApplicationFiled: May 1, 2017Publication date: May 16, 2019Applicants: NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER, FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBEInventors: Tadamasa MATSUMOTO, Masafumi IHARA, Satoshi SAITO, Masanori FUKUSHIMA
-
Patent number: 9301917Abstract: Provided is a pharmaceutical composition, including a drug and a collagen, in which the composition is satisfactory in handleability and has sustained-release property. The sustained-release pharmaceutical composition includes: a drug; a collagen; and at least one kind of sugar selected from monosaccharides, disaccharides, trisaccharides, and tetrasaccharides. The inventors of the present invention have found that the in vivo administration of a collagen solution containing a sugar results in the gelation of a collagen. Based on this finding, the inventors have found that a composition containing a drug, a collagen, and a sugar can control the release rate of the drug, and such composition can be used as a sustained-release pharmaceutical composition.Type: GrantFiled: October 14, 2011Date of Patent: April 5, 2016Assignees: Kyoto University, Kyoto Prefectural Public University Corporation, Kaken Pharmaceutical Co., Ltd., Koken Co., Ltd.Inventors: Masanori Fukushima, Hiroaki Matsubara, Satoaki Matoba, Shigeki Hijikata, Yu Aso, Tsutomu Sato
-
Publication number: 20130225492Abstract: Provided is a pharmaceutical composition, including a drug and a collagen, in which the composition is satisfactory in handleability and has sustained-release property. The sustained-release pharmaceutical composition includes: a drug; a collagen; and at least one kind of sugar selected from monosaccharides, disaccharides, trisaccharides, and tetrasaccharides. The inventors of the present invention have found that the in vivo administration of a collagen solution containing a sugar results in the gelation of a collagen. Based on this finding, the inventors have found that a composition containing a drug, a collagen, and a sugar can control the release rate of the drug, and such composition can be used as a sustained-release pharmaceutical composition.Type: ApplicationFiled: October 14, 2011Publication date: August 29, 2013Applicants: KYOTO UNIVERSITY, KOKEN CO., LTD., KAKEN PHARMACEUTICAL CO., LTD., KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATIONInventors: Masanori Fukushima, Hiroaki Matsubara, Satoaki Matoba, Shigeki Hijikata, Yu Aso, Tsutomu Sato
-
Patent number: 7428659Abstract: A programmable controller includes two CPU units each having a detachably attached special-function module for carrying out a calculation process, each of the two CPU units recognizing conditions of the other CPU unit, one of them becoming an active unit and the other becoming a standby unit such that when the active unit fails and goes down the standby unit is switched to become active and resumes operations. The special-function module attached to the active CPU unit becomes an active module and carries out control processes with the active CPU unit and the other special-function module attached to the standby CPU unit becomes a standby module.Type: GrantFiled: June 4, 2003Date of Patent: September 23, 2008Assignee: OMRON CorporationInventors: Eisuke Nagano, Masanori Fukushima, Kenichiro Tomita, Kazuaki Tomita
-
Publication number: 20040025078Abstract: A programmable controller includes two CPU units each having a detachably attached special-function module for carrying out a calculation process, each of the two CPU units recognizing conditions of the other CPU unit, one of them becoming an active unit and the other becoming a standby unit such that when the active unit fails and goes down the standby unit is switched to become active and resumes operations. The special-function module attached to the active CPU unit becomes an active module and carries out control processes with the active CPU unit and the other special-function module attached to the standby CPU unit becomes a standby module.Type: ApplicationFiled: June 4, 2003Publication date: February 5, 2004Inventors: Eisuke Nagano, Masanori Fukushima, Kenichiro Tomita, Kazuaki Tomita
-
Patent number: 6540444Abstract: The rotating pile for undergrounding contains a pile-head pipe having a longitudinal center line, a pipe wall, one end portion, and the other end portion opposite to the one end portion. Three or four recessed portions in which the pipe wall is recessed toward the center line are formed in the one end portion. Blades defined by the pipe wall are formed between the adjacent recessed portions. Each of the recessed portions is inclined from the circumferential surface of the pile-head pipe toward the center line. The pipe wall defining one of the adjacent recessed portions contact with the pipe wall defining the other recessed portion so as to cause the one end to be substantially closed. The blades extend radially outward from the center line. The blades gradually expand in the circumferential direction of the pile-head pipe from its top end toward its base end portion.Type: GrantFiled: January 22, 2002Date of Patent: April 1, 2003Assignee: Fukushima Pulse Co., Ltd.Inventor: Masanori Fukushima
-
Publication number: 20020098045Abstract: The rotating pile for undergrounding contains a pile-head pipe having a longitudinal center line, a pipe wall, one end portion, and the other end portion opposite to the one end portion. Three or four recessed portions in which the pipe wall is recessed toward the center line are formed in the one end portion. Blades defined by the pipe wall are formed between the adjacent recessed portions. Each of the recessed portions is inclined from the circumferential surface of the pile-head pipe toward the center line. The pipe wall defining one of the adjacent recessed portions contact with the pipe wall defining the other recessed portion so as to cause the one end to be substantially closed. The blades extend radially outward from the center line. The blades gradually expand in the circumferential direction of the pile-head pipe from its top end toward its base end portion.Type: ApplicationFiled: January 22, 2002Publication date: July 25, 2002Applicant: FUKUSHIMA PULSE Co., Ltd.Inventor: Masanori Fukushima